Rocket Pharmaceuticals- Warrants (02/09/2026) Total Liabilities

As of the most recent data (June 2026), RCKTW shows a total liabilities of $54M. That compares with $67M in the prior-year period — down 18.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RCKTW's total liabilities is now $54M (was $67M) — a 18.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rocket Pharmaceuticals- Warrants (02/09/2026) is outperforming or lagging.

Tracking RCKTW's total liabilities over time shows whether Rocket Pharmaceuticals- Warrants (02/09/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $54M That compares with $67M in the prior-year period — down 18.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Rocket Pharmaceuticals- Warrants (02/09/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $54M) with ownership activity and broader fundamentals.

Rocket Pharmaceuticals- Warrants (02/09/2026)'s total liabilities is $54M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.